TY - CHAP
T1 - I tumori della mammella e/o dell’ovaio di tipo eredofamiliare:
strategie di prevenzione nelle donne ad alto
rischio
AU - Calò, V; Bruno, L; Cicero, G; Guarneri, G; Dispenza, N
AU - Gebbia, Nicolo'
AU - Gerbino, Aldo
AU - Frazzetta, Michele
AU - Russo, Antonio
AU - Pantuso, Gianni
AU - Bazan, Viviana
AU - Sandonato, Luigi
AU - Lo Dico, Giuseppe
AU - Cajozzo, Massimo
AU - Grassi, Nello
AU - Rizzo, Sergio
AU - Bronte, Giuseppe
PY - 2009
Y1 - 2009
N2 - Several factors should be taken into account to estimate the risk for breast and ovarian cancer
development such as age, reproductive and hormonal factors including parity and oral contraceptive use,
strong family history of breast and ovarian cancer, and – to a lesser extend – environmental and lifestyle
factors.
Management options for the women at high-risk for breast and ovarian cancer development include prophylactic
surgery (i.e. bilateral mastectomy and bilateral ovarosalpingectomy), chemoprevention (using mainly
tamoxifen, but also raloxifen, and - recently - aromatase inhibitors in high-risk post-menopausal women),
lifestyle changes and intensive surveillance which includes regular clinical examination, regular Magnetic
Resonance Imaging, Mammography potentially in association with breast Ultrasonography, and ovarian cancer
surveillance with transvaginal ultrasound and CA125 combined.
AB - Several factors should be taken into account to estimate the risk for breast and ovarian cancer
development such as age, reproductive and hormonal factors including parity and oral contraceptive use,
strong family history of breast and ovarian cancer, and – to a lesser extend – environmental and lifestyle
factors.
Management options for the women at high-risk for breast and ovarian cancer development include prophylactic
surgery (i.e. bilateral mastectomy and bilateral ovarosalpingectomy), chemoprevention (using mainly
tamoxifen, but also raloxifen, and - recently - aromatase inhibitors in high-risk post-menopausal women),
lifestyle changes and intensive surveillance which includes regular clinical examination, regular Magnetic
Resonance Imaging, Mammography potentially in association with breast Ultrasonography, and ovarian cancer
surveillance with transvaginal ultrasound and CA125 combined.
KW - tumori, mammella, ovaio , prevenzione
UR - http://hdl.handle.net/10447/44612
M3 - Chapter
SN - 978-88-89876-15-2
T3 - RICERCA
SP - 249
EP - 266
BT - Experimental medicine reviews [Vol. 2/3]
ER -